QBL EMERGING as a KEY PLAYER in CANNABIS scene - latest
QBL EMERGING as a KEY PLAYER in CANNABIS scene - latest update come with a full interview on Sky News; https://www.skynews.com.au/details/_5705346370001
To understand the question of why QBL was selected to become a partner; management and Andrew Kavasilas (cannabis expert with 20 years experience) knew each other from the past.
I reckon MCL understood it was a to big piece to chew of to start on there own; it cost a lot to register a company on the stockexchange, they had no revenue when approached QBL, to join a company who is listed on the stockexchange - who where willing to cut a deal despite it`s not in there sector... that makes sense to me.
A lot of business end up in confidence; the personal connections between Andrew and QBL management was a cruical thing. Now a bit more then a year later - QBL subsidiary are generating revenue (they are selling more then they can supply at the moment!) threw hemp with a set of various ( products.
Consider revenue from MMJ is the next step - things look really good. To come in on the groundfloor at this setup, I feel gratefull. As I see it at the end of the day; the potential is gigantic. The risk is small when you evaluate the facts; revenue coming in and business are growing nicely. 7,5 million in cash and no debt.
Here you have the opportunity to take advantage on facts and info from QBL. Like the ”QBL on ASX” chapter, who can provide verified facts; here is also regulated on-line stockbrokers suggestion, no games info and a good sum up. Voluntary suspension is requested regarding a significant and strategic acquisition by QBL’s subsidiary Medical Cannabis Limited until Friday 25 th or before. Contact information to the QBL Investor service, who can reply on questions.
https://www.queenslandbauxite.com/ https://www.queenslandbauxite.com/ (remember different timezones outside Australia, trade pre-start 7 AM in Sydney, local time, trade opens 10 AM)
Robert
Scroll down for more posts ▼
Top 10 Most Recent News Articles
OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...
Continue Reading
The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...
Continue Reading
Call me old-fashioned, but when cancer whispers in the shadows even after it's supposedly signed off the death certificate, you're dealing with one heck of a slippery adversary. That's where Montefiore Einstein Comprehensive Cancer Center comes in, armed with ten million greenbacks from the National Cancer Institute, primed to rattle the labyrinth of breast cancer...
Continue Reading
Tulsa's New Spotlight: Gradient's CHROMA Event Well, look at Tulsa, becoming the center of the tech and enterprise universe for a day. Gradient is throwing open the doors for its second annual CHROMA event on September 24, 2026. You might scratch your head and say, ‘Tulsa? Really?’ But hear me out—this isn’t just a local shindig. We're talking about a one-day...
Continue Reading
Breaking New Ground in Thyroid Eye Disease Treatment If there's one thing that keeps the biopharma world on its toes, it's the relentless pursuit of groundbreaking treatments. And folks, let me tell you, the latest tie-up between Minghui Pharmaceutical and ASKA Pharmaceutical has struck a chord. This union with MHB018A at its core might be one of those watershed moments...
Continue Reading
Cloud Software Group is stirring the pot with an amendment that'll have bondholders looking twice at their portfolios. On November 3, 2026, the company announced a tweak to its cash tender offer, bumping up the payment for its 9.00% Senior Secured Second Lien Notes due 2029. The payout now jumps from $1,017.50 to $1,022.50 for each $1,000 of principal. If you're holding...
Continue Reading
Unraveling the Real-World Evidence Landscape in Japan The folks at TXP Medical just dropped a bombshell of a whitepaper that'll have Medical Affairs departments buzzing. Imagine waking up to a market that's exploding by over 500% in just a decade—yeah, I'm talking about the EMR-derived data market in Japan. These guys are saying it's gonna shoot from ¥3.9 billion in...
Continue Reading
A Bold Step Into the Hydrogen Era Hyundai's really stepping it up at the World Hydrogen Expo 2026. They're not just dipping their toes in the hydrogen pool—they're diving in headfirst, showing off integrated hydrogen solutions that are nothing short of ambitious. Hydrogen Production That's a Real Game Changer This ain't just talk. Hyundai's showcasing modular PEM...
Continue Reading
Stablecoin Strategy Meets Institutional Investment Here's a fresh one from the digital asset universe. We're talking about Qapture Investments' bold move to launch an institutional-grade stablecoin yield strategy. This ain't your average kitchen table crypto chat—it's the Qapture Safe Haven Vault (QHVN-USD), tailored for those looking to get a better return on their...
Continue Reading
Hormel Foods Prepares for Earnings Spotlight In a world where market instability feels like the only constant, Hormel Foods Corporation (NYSE:HRL) is setting up one of those must-watch moments. You've got DECEMBER 3rd circled on your cal, right? If not, you're about to miss a curtain raiser that could send ripples across portfolios. Setting the Stage: December's Big...
Continue Reading
Top 5 Most Recently Viewed Articles
KAYALI Introduces Exciting New Fragrances KAYALI, the extraordinary fragrance house created by Mona Kattan, has once again captivated the world by expanding its popular Oudgasm Collection. The new scents include Oudgasm Chocolate Oud | 11 Eau de Parfum Intense and Oudgasm Milky Musk Oud | 30 Eau de Parfum Intense. These additions offer an innovative twist on oud, one of...
Continue Reading
Ingersoll Rand Inc. (NYSE: IR) was gearing up to drop its third-quarter earnings in October 2024, and you know how these releases can shake the tree. With the market closing on a Thursday, traders were already calculating their bets ahead of this release—a classic pre-weekend play where anything could happen. What Traders Anticipated from Ingersoll Rand's Q3 Earnings...
Continue Reading
AppWork Secures $13 Million in Series A Funding Investment will accelerate product development and customer success as AppWork scales its industry-leading platform AppWork, a fast-growing software platform designed to optimize maintenance operations for multifamily property management teams, has successfully secured $13 million in Series A funding. The investment was led...
Continue Reading
Mecho Enhances Sustainability with EcoGlass Blackout Mecho, a renowned leader in commercial shading solutions, has recently accomplished a significant sustainability milestone by introducing Environmental Product Declarations (EPDs) for its motorized shade systems, alongside its groundbreaking product EcoGlass Blackout. This innovative blackout fabric is the first of its...
Continue Reading
Vivoryon Therapeutics N.V. Announces Q1 2025 Financial Results Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) is gearing up to unveil its financial results for the first quarter of 2025. This announcement is pivotal as it not only reflects the company's financial health but also signals its ongoing commitment to advancing treatments for inflammatory...
Continue Reading
